// App-Quantinova.ai

[FRI0322] : CANAKINUMAB IN PATIENTS WITH CHRONIC TOPHACEOUS GOUT, RESISTANT TO CURRENT TREATMENT OPTIONS

Researchers

Presenter

  • M.S. Eliseev

Principal Investigators

  • O.V. Zhelyabina

  • M.V. Mukagova

  • E. Nasonov. V. A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Gout/hyperuricemia

  • Osteoporosis

  • Inflammatory Arthritis

  • Gout

Biomarkers

  • High sensitivity C-reactive protein

  • Interleukin 1

Drug/Treatment

  • Allopurinol

  • canakinumab (SC)

  • Colchicine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved